The purpose of this study is to record and evaluate the use of traditional morphology grading combined with Eeva in the treatment of in vitro fertilization.

This is a prospective, observational, single-arm, nonrandomized, multicenter study. Data will be collected to establish eligibility, at baseline, during the stimulation and in vitro fertilization process, during embryo culture, at embryo transfer, at 12-18 days post egg retrieval to verify biochemical pregnancy, and then typically at 5-6 weeks gestational weeks to verify clinical pregnancy.

Inclusion Criteria:

• women undergoing fresh in vitro fertilization treatment using their own eggs or donor eggs.

Exclusion Criteria:

• history of cancer.
• gestational carrier.

Patients undergoing in vitro fertilization treatment who provide informed consent and use Eeva in their treatment cycle.